Tae-bum B. Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

Journal: The journal of allergy and clinical immunology. In practice
Published: February 25, 2026

Resistin signaling via NF-κB pathway plays a key role in obesity-induced and -aggravated asthma.

Resistin signaling via NF-κB pathway plays a key role in obesity-induced and -aggravated asthma.

Journal: Life sciences
Published: January 02, 2026

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Journal: The journal of allergy and clinical immunology. In practice
Published: August 20, 2025

Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma.

Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma.

Journal: Allergy, asthma & immunology research
Published: April 05, 2025

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Journal: The journal of allergy and clinical immunology. In practice
Published: February 04, 2025

Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study.

Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study.

Journal: Allergy, asthma & immunology research
Published: January 08, 2025

Single-cell RNA sequencing reveals transcriptional changes in circulating immune cells from patients with severe asthma induced by biologics.

Single-cell RNA sequencing reveals transcriptional changes in circulating immune cells from patients with severe asthma induced by biologics.

Journal: Experimental & molecular medicine
Published: April 26, 2024

Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study.

Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study.

Journal: Lung
Published: March 29, 2024

Clinical Characteristics of T2-Low and T2-High Asthma-Chronic Obstructive Pulmonary Disease Overlap: Findings From COREA Cohort.

Clinical Characteristics of T2-Low and T2-High Asthma-Chronic Obstructive Pulmonary Disease Overlap: Findings From COREA Cohort.

Journal: Allergy, asthma & immunology research
Published: February 12, 2024

Assessment of Treatment Response in Patients With Severe Asthma Using Visual and Quantitative Analysis of Chest CT.

Assessment of Treatment Response in Patients With Severe Asthma Using Visual and Quantitative Analysis of Chest CT.

Journal: Korean journal of radiology
Published: January 29, 2024

Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis.

Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis.

Journal: Allergy, asthma & immunology research
Published: December 11, 2023

Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study.

Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study.

Journal: Lung
Published: October 31, 2023
Showing 1-12 of 76

Last Updated: 09/26/2026